These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32229249)

  • 21. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres.
    Kuchinke W; Ohmann C; Yang Q; Salas N; Lauritsen J; Gueyffier F; Leizorovicz A; Schade-Brittinger C; Wittenberg M; Voko Z; Gaynor S; Cooney M; Doran P; Maggioni A; Lorimer A; Torres F; McPherson G; Charwill J; Hellström M; Lejeune S
    Trials; 2010 Jul; 11():79. PubMed ID: 20663165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials.
    Niranjan SJ; Durant RW; Wenzel JA; Cook ED; Fouad MN; Vickers SM; Konety BR; Rutland SB; Simoni ZR; Martin MY
    J Cancer Educ; 2019 Feb; 34(1):26-34. PubMed ID: 28776305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN).
    Madeira C; Pais A; Kubiak C; Demotes J; Monteiro EC
    Contemp Clin Trials Commun; 2016 Dec; 4():141-148. PubMed ID: 29736477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to the conduct of randomised clinical trials within all disease areas.
    Djurisic S; Rath A; Gaber S; Garattini S; Bertele V; Ngwabyt SN; Hivert V; Neugebauer EAM; Laville M; Hiesmayr M; Demotes-Mainard J; Kubiak C; Jakobsen JC; Gluud C
    Trials; 2017 Aug; 18(1):360. PubMed ID: 28764809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The UK clinical research network--has it been a success for dermatology clinical trials?
    Thomas KS; Koller K; Foster K; Perdue J; Charlesworth L; Chalmers JR
    Trials; 2011 Jun; 12():153. PubMed ID: 21679433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European survey on national training activities in clinical research.
    Magnin A; Iversen VC; Calvo G; Čečetková B; Dale O; Demlova R; Blasko G; Keane F; Kovacs GL; Levy-Marchal C; Monteiro EC; Palmisano L; Pella D; Portolés Pérez A; Rascol O; Schmid C; Tay F; von der Leyen H; Ohmann C
    Trials; 2019 Oct; 20(1):616. PubMed ID: 31665085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study).
    Gabbay MB; Ring A; Byng R; Anderson P; Taylor RS; Matthews C; Harris T; Berry V; Byrne P; Carter E; Clarke P; Cocking L; Edwards S; Emsley R; Fornasiero M; Frith L; Harris S; Huxley P; Jones S; Kinderman P; King M; Kosnes L; Marshall D; Mercer D; May C; Nolan D; Phillips C; Rawcliffe T; Sardani AV; Shaw E; Thompson S; Vickery J; Wainman B; Warner M
    Health Technol Assess; 2017 Jun; 21(35):1-164. PubMed ID: 28648148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do investigator meetings improve recruitment rates in clinical trials? A retrospective before-and-after study of data from nine multi-centre clinical trials.
    Mitchell EJ; Godolphin PJ; Meakin G; Sprange K
    Trials; 2020 Jun; 21(1):514. PubMed ID: 32522228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials.
    Boden-Albala B; Carman H; Southwick L; Parikh NS; Roberts E; Waddy S; Edwards D
    Stroke; 2015 Aug; 46(8):2232-7. PubMed ID: 26185186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and management.
    Kyte D; Ives J; Draper H; Calvert M
    BMJ Open; 2016 Oct; 6(10):e012281. PubMed ID: 27697875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol.
    Retzer A; Keeley T; Ahmed K; Armes J; Brown JM; Calman L; Copland C; Efficace F; Gavin A; Glaser A; Greenfield DM; Lanceley A; Taylor RM; Velikova G; Brundage M; Mercieca-Bebber R; King MT; Calvert M; Kyte D
    BMJ Open; 2018 Feb; 8(2):e017282. PubMed ID: 29431123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a European Clinical Research Infrastructures Network: the ECRIN programme.
    Demotes-Mainard J
    Therapie; 2004; 59(1):151-3. PubMed ID: 15199684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interim recruitment prediction for multi-center clinical trials.
    Urbas S; Sherlock C; Metcalfe P
    Biostatistics; 2022 Apr; 23(2):485-506. PubMed ID: 32978616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesizing existing evidence to design future trials: survey of methodologists from European institutions.
    Nikolakopoulou A; Trelle S; Sutton AJ; Egger M; Salanti G
    Trials; 2019 Jun; 20(1):334. PubMed ID: 31174597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruiting faith- and non-faith-based schools, adolescents and parents to a cluster randomised sexual-health trial: experiences, challenges and lessons from the mixed-methods Jack Feasibility Trial.
    Aventin Á; Lohan M; Maguire L; Clarke M
    Trials; 2016 Jul; 17():365. PubMed ID: 27473584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining a risk-proportionate approach to the validation of statistical programming for clinical trials.
    Gamble C; Lewis S; Stocken D; Juszczak E; Bradburn M; Doré C; Kean S
    Clin Trials; 2024 Feb; 21(1):85-94. PubMed ID: 37957825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?
    Rath A; Salamon V; Peixoto S; Hivert V; Laville M; Segrestin B; Neugebauer EAM; Eikermann M; Bertele V; Garattini S; Wetterslev J; Banzi R; Jakobsen JC; Djurisic S; Kubiak C; Demotes-Mainard J; Gluud C
    Trials; 2017 Nov; 18(1):556. PubMed ID: 29166947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician Perceptions of the Use of Social Media for Recruitment of Patients in Cancer Clinical Trials.
    Sedrak MS; Sun V; Liu J; George K; Wong AR; Dale W; Dizon DS
    JAMA Netw Open; 2019 Sep; 2(9):e1911528. PubMed ID: 31532517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using evidence when planning for trial recruitment: An international perspective from time-poor trialists.
    Gardner HR; Treweek S; Gillies K
    PLoS One; 2019; 14(12):e0226081. PubMed ID: 31821373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.